If you are wondering whether HeartFlow’s share price matches its underlying worth, you are not alone. This article is here to break that question down in plain terms.
HeartFlow shares most recently closed at US$33.14, with returns of 14.4% over the past week, 18.1% over the last 30 days, and 14.4% year to date. This has put the stock on more investors’ radar.
Recent news coverage around HeartFlow has focused on investor interest in the broader healthcare and medical technology space, with commentators highlighting how new listings and younger names are attracting attention. This backdrop helps explain why a move of this size over a short period can draw questions about whether the current price is stretching ahead of fundamentals or simply catching up.
On Simply Wall St’s valuation checks, HeartFlow currently has a valuation score of 0 out of 6. In the sections ahead we will look at what that means under different valuation methods, and then finish with a framework that can help you make sense of these numbers in a more holistic way.
HeartFlow scores just 0/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.
A Discounted Cash Flow, or DCF, model takes estimates of the cash a business could generate in the future and discounts those back into today’s dollars to arrive at an estimate of what the whole company might be worth now.
For HeartFlow, the model used is a 2 Stage Free Cash Flow to Equity approach. The latest twelve month free cash flow is a loss of about $57.47 million. Analyst and extrapolated projections run out to 2035. The ten year path includes years of negative free cash flow and then positive figures such as $14.50 million in 2029 and $40.58 million in 2035, all in $ and mostly based on a mix of analyst input and Simply Wall St extrapolation beyond the typical five year analyst horizon.
After discounting these projected cash flows back to today, the model suggests an intrinsic value of about $4.64 per share. Compared with the recent share price of US$33.14, this implies the stock is very expensive relative to what this DCF model supports.
Result: OVERVALUED
Our Discounted Cash Flow (DCF) analysis suggests HeartFlow may be overvalued by 614.2%. Discover 879 undervalued stocks or create your own screener to find better value opportunities.
HTFL Discounted Cash Flow as at Jan 2026
Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for HeartFlow.
For companies that are not yet generating consistent profits, the P/S ratio is often more useful than P/E because it focuses on revenue rather than earnings, which can still be negative during an early growth phase.
In general, higher growth expectations and lower perceived risk can support a higher P/S multiple. Slower growth and higher risk tend to justify a lower, more conservative range. That is why it helps to compare a company’s P/S to a few different yardsticks rather than looking at the headline number in isolation.
HeartFlow currently trades on a P/S of 17.43x. This is well above the Healthcare Services industry average of 2.27x and also ahead of the peer group average of 2.90x. Simply Wall St’s proprietary Fair Ratio aims to estimate what a reasonable P/S multiple could be for HeartFlow, given its earnings profile, industry, profit margins, market cap and company specific risks.
The Fair Ratio is designed to be more tailored than a simple peer or industry comparison because it adjusts for growth, risk and profitability rather than assuming all Healthcare Services companies deserve similar multiples. In HeartFlow’s case, the current P/S of 17.43x sits materially above the Fair Ratio estimate, which points to the shares trading on a rich revenue multiple.
Result: OVERVALUED
NasdaqGS:HTFL P/S Ratio as at Jan 2026
P/S ratios tell one story, but what if the real opportunity lies elsewhere? Discover 1444 companies where insiders are betting big on explosive growth.
Earlier we mentioned that there is an even better way to understand valuation, so let us introduce you to Narratives, which sit on Simply Wall St’s Community page and are used by millions of investors.
A Narrative is your story about a company, written in numbers, where you set out what you think is a reasonable fair value along with your expectations for future revenue, earnings and margins instead of relying only on one static model. What makes Narratives powerful is that they link three pieces together in a clear line: the company’s story, the financial forecast that follows from that story, and the fair value that drops out of that forecast.
On the platform, Narratives are easy to use. You pick your assumptions, see the implied fair value, then compare that to the current share price to help you decide whether you see HeartFlow as closer to a buy, a hold, or a sell for your own situation. As new information arrives, such as news or earnings releases, the Narrative updates so your view does not sit frozen while the facts change around it. For HeartFlow you might see one Narrative with a very low fair value and cautious revenue forecasts next to another with a much higher fair value and more optimistic estimates.
Do you think there’s more to the story for HeartFlow? Head over to our Community to see what others are saying!
NasdaqGS:HTFL 1-Year Stock Price Chart
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include HTFL.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]
